Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Suzhou Ribo Life Science
Watchlist
Suzhou Ribo Life Science (瑞博生物) Pre-IPO Quick View: Scarcity of SiRNA Player
Equity Capital Markets
188 Views
02 May 2025 02:00
Suzhou Ribo Life plans to raise $100 million through a Hong Kong listing, with CICC and Citi as deal sponsors. They are a leading company in siRNA research.
What is covered in the Full Insight:
Introduction to Suzhou Ribo Life Science
Company's Key Products and Clinical Progress
Partnerships and Collaborations
Financial Overview and Pre-IPO Investors
Initial Market Impressions and Considerations
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »
Loading
Trending Collections
More »
South Korea
Japan
India
Event-Driven
Index Rebalance
Sell / Short Ideas
Asia ECM
Equity Bottom-Up
Pair Trades and Long/Short Ideas
Philippines
Trending Insights
More »
PointsBet (PBH AU): Betr's "Superior Offer"? In An Alternate Reality
Xero (XRO AU): Index Flows Following the Capital Raise
Shin Kong (2888 TT)/Taishin (2887 TT) - Short Timer, FX Risk, Index Flows - Time To Buy Vs Peers
S&P/ASX Indices: Proposed Methodology Changes & The BIG September Rebalance
NIFTY200 Momentum30 Index Rebalance: HUGE Turnover and Trade as Financials Shine
Top Unpaywalled Insights
More »
Loading
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Loading...
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x